LungVITamin D and OmegA-3 Trial [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms lungVITAL
- 07 Mar 2017 The trial design and patient population details published in the Contemporary Clinical Trials
- 21 May 2014 The trial design and patient population details presented at 110th International Conference of the American Thoracic Society.
- 08 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.